Mitchell Glass
6Patents
3h-index
5Co-inventors
50Inventor score
Filing activity: May 24, 1990 → Jan 9, 2012
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6670398B2 | Compounds and methods for treating transplant rejection | Chemistry; Metallurgy | 28 | Expired |
| US5162348A | Treatment of cystic fibrosis | Human Necessities | 8 | Expired |
| US7087645B2 | Compounds and methods for treating transplant rejection | Chemistry; Metallurgy | 4 | Expired |
| US5338727A | Therapeutic agent for the prevention or treatment of adult respiratory distress syndrome | Human Necessities | 2 | Expired |
| US5128322A | Agent for therapy | Human Necessities | 1 | Expired |
| US9993444B2 | Use of beta-adrenergic inverse agonists for smoking cessation | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.